Treatment of renal cell carcinoma with 5-fluorouracil and alfa- interferon

Urology

Volumn 50, Issue 6, 1997, Pages 863-868

  Gebrosky, Norman P ^b   Koukol, Stephen ^b   Nseyo, Unyime O ^b   Carpenter, Cindy ^b   Lamm, Donald L ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; LEUKOPENIA; MALE; NEUROTOXICITY; PRIORITY JOURNAL; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2B; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEPHRECTOMY; REMISSION INDUCTION;

EID: 0031450065     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00542-6     Document Type: Article

References (17)

1. Taneja SS, Pierce W, Figlin R, and Belldegrun A: Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment. Urology 45: 911-924, 1995.
2. Maldazys JD, and DeKernion JB: Prognostic factors in metastatic renal carcinoma. J Urol 136: 376-379, 1986.
3. Muss HB: Interferon therapy of metastatic renal cell cancer. Semin Surg Oncol 4: 199-203, 1988.
4. Sama G, Figlin R, and DeKernion J: Interferon in renal cell carcinoma: the UCLA experience. Cancer 50: 610-612, 1987.
5. Buzaid AC, Robertone A, Kisala C, and Salmon SE: Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinoma. J Clin Oncol 5: 1083-1089, 1987.
6. Tsavaris N, Mylonakis N, Bacoyiannis C, Tsoutsos H, Karabelis A, and Kosmidis P: Treatment of renal cell carcinoma with escalating doses of alpha-interferon. Chemotherapy 39: 361-366, 1993.
7. Romero JA, Alvarez-Vijande R, Gil-Vernet JM Jr, Samson R, Fernandez I, Gutierrez R, and Cerretero P: Alfa-interferon and oral fluorouracil in the treatment of unremovable and/or metastatic renal cancer. Eur Urol 20: 16-18, 1991.
8. Stella A, Logothetis C, Fritz K, Dexeus F, Amato R, Kilbourn R, and Wallace S: Recombinant interferon a (Roferon®) combined with 5-fluorouracil based chemotherapy in metastatic renal cell cancer. J Urol 145(Pt. 2): 273A, 1991.
9. Schuth J, Goldschmidt JW, and Tunn UW: Response in patients with metastatic renal cell carcinoma (RCC) during the treatment with alfa interferon in combination with 5-fluorouracil. Eur J Cancer 29: 234-236, 1993.
10. Haarstad H, Jacobsen AB, Schjølseth, SA, Risberg T, Fossa SD, and Schjlseth SA: Interferon-alpha, 5-FU, and prednisone in metastatic renal cell carcinoma: a phase II study. Ann Oncol 5: 245-248, 1994.
11. Sella A, Logothetis CJ, Fitz K, Dexeus FH, Amato R, Kilbourn R, and Wallace S: Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer. J Urol 147: 573-577, 1992.
12. Sella A, Zukiwski A, Robinson E, Kilbourn R, Ellerhorst J, Amato R, and Logothetis C: Interleukin-2 (IL-2) with interferon-alpha (IFN-alpha) and 5-fluorouracil (5-FU) in patients (pts) with metastatic renal cell center (RCC). Proc Annu Meet Am Soc Clin Oncol 13: 237, 1994.
13. Atzpodien J, Kirchner H, Lopez Hanninen E, Fenner M, and Poliwada H: Alpha-interferon, interleukin-2, and 5-fluorouracil as a promising biochemotherapy regimen for the management of advanced renal cell carcinoma. Proc Annu Meet Am Soc Clin Oncol 12: 230, 1993.
14. Fossa SD, DeGaris ST, Heier MS, Flokkmann A, Lien HH, Salveson A, and Moe B: Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma. Cancer 57: 1700-1704, 1986.
15. Emoto N, Isozaki O, Ohmura E, Ito F, Tsushima T, Shizume K, Demura H, and Toma H: Basic fibroblast growth factor (FGF-2) in renal cell carcinoma, which is indistinguishable from that in normal kidney, is involved in renal cell carcinoma growth. J Urol 152: 1626-1631, 1994.
16. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, and Fidler IJ: Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92: 4562-4566, 1995.
17. Murphy BR, Rynard SM, Einhorn LH, and Loehrer PJ: A phase II trial of interferon alfa-2a plus fluorouracil in advanced renal cell carcinoma. Invest New Drugs 10: 225-230, 1992.